Trigeminal neuralgia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:221091OMIM:190400G50.0
Who is this for?
Show terms as
1FDA treatments26Active trials24Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Trigeminal neuralgia (TN), also known as tic douloureux or Fothergill's disease, is a chronic pain condition affecting the trigeminal nerve (cranial nerve V), which is responsible for carrying sensation from the face to the brain. It is characterized by sudden, severe, brief, stabbing, recurrent episodes of unilateral facial pain in the distribution of one or more branches of the trigeminal nerve, most commonly the maxillary (V2) and mandibular (V3) divisions. The pain is often described as electric shock-like and can be triggered by everyday activities such as eating, talking, brushing teeth, touching the face, or even a light breeze. Episodes may last from a fraction of a second to about two minutes and can occur in rapid succession. Between attacks, patients may be pain-free, though some individuals develop a continuous background aching or burning pain. Trigeminal neuralgia is classified into classical (formerly 'typical'), secondary, and idiopathic forms. Classical TN is most often caused by neurovascular compression of the trigeminal nerve root near the brainstem, typically by the superior cerebellar artery. Secondary TN may result from an underlying condition such as multiple sclerosis or a cerebellopontine angle tumor. The condition predominantly affects adults, with onset typically after age 50, and is slightly more common in women than men. The right side of the face is affected more frequently than the left. First-line treatment is pharmacological, with carbamazepine and oxcarbazepine being the most established and effective medications for reducing the frequency and severity of attacks. Other medications such as baclofen, lamotrigine, and gabapentin may be used as adjuncts or alternatives. When medical therapy fails or becomes intolerable due to side effects, surgical options are available. These include microvascular decompression (MVD), which addresses the underlying neurovascular compression and offers the highest rate of long-term pain relief; percutaneous procedures such as balloon compression, glycerol rhizolysis, or radiofrequency thermocoagulation of the Gasserian ganglion; and stereotactic radiosurgery (Gamma Knife). The choice of treatment depends on the patient's age, overall health, type of TN, and response to prior therapies.

Clinical phenotype terms— hover any for plain English:

Trigeminal neuralgiaHP:0100661Cluster headacheHP:0012199AllodyniaHP:0012533Tongue muscle weaknessHP:0000183Episodic paroxysmal anxietyHP:0000740Vascular tortuosityHP:0004948Mandibular painHP:0200025Cranial nerve compressionHP:0001293CNS demyelinationHP:0007305Peripheral demyelinationHP:0011096
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Apr 2026Identification of Possible Trigeminal Neuralgia

University College, London

TrialNOT YET RECRUITING
Apr 2026Resting-State fMRI Study of Functional Connectivity After Gamma Knife Radiosurgery in Trigeminal Neuralgia

Assistance Publique Hopitaux De Marseille — NA

TrialNOT YET RECRUITING
Mar 2026The Alternative Effects of Electroacupuncture in the Treatment of Trigeminal Neuralgia

Yuanyuan Wu — NA

TrialNOT YET RECRUITING
Dec 2025Risk Factors for Recurrence of Trigeminal Neuralgia After Percutaneous Balloon Compression

Second Xiangya Hospital of Central South University

TrialNOT YET RECRUITING
Dec 2025Post-Operative Trigeminal Pain After Microvascular Decompression for Trigeminal Neuralgia

Rutgers, The State University of New Jersey

TrialNOT YET RECRUITING
Dec 2025Efficacy and Safety of Irregular Pulsed Radiofrequency (Sluijter-Teixera Poisson) Versus Regular Pulsed Radiofrequency to the Gasserian Ganglion for Treatment of Primary Trigeminal Neuralgia

Sohag University — NA

TrialNOT YET RECRUITING
Oct 2025Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict

Gerrit A Schubert

TrialNOT YET RECRUITING
Jul 2025Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN

University of Alberta — PHASE2

TrialRECRUITING
Jul 2025The Synergism and Attenuation Effects of Electroacupuncture in the Treatment of Trigeminal Neuralgia

Yuanyuan Wu — NA

TrialNOT YET RECRUITING
Jun 2025Comparison of Two Types of Radiofrequency Treatment for Trigeminal Neuralgia

Mesut Bakır — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

CARBAMAZEPINE

CARBAMAZEPINE· Alembic Pharmaceuticals Inc.■ Boxed Warning

Carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia

Clinical Trials

20 recruitingView all trials with filters →
Phase 42 trials
Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal Neuralgia
Phase 4
Active
PI: Dr. Rizwana Malahat Ahmad, MBBS (Jinnah Postgraduate Medical Centre) · Sites: Karachi, Sindh · Age: 2580 yrs
OnabotulinumtoxinA for Trigeminal Neuralgia
Phase 4
Actively Recruiting
PI: Meredith Barad, MD (Stanford University) · Sites: Stanford, California · Age: 1899 yrs
Phase 23 trials
Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia
Phase 2
Enrolling by Invitation
· Sites: Beijing, Beijing Municipality · Age: 1875 yrs
Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN
Phase 2
Actively Recruiting
· Sites: Edmonton, Alberta; Edmonton, Alberta · Age: 1899 yrs
Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia
Phase 2
Active
PI: Bifa Fan, MD (China-Japan Friendship Hospital) · Sites: Beijing · Age: 1885 yrs
Phase 11 trial
Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion
Phase 1
Actively Recruiting
· Sites: Sherbrooke, Quebec · Age: 1899 yrs
N/A8 trials
Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment
N/A
Actively Recruiting
PI: Tuba Tanyel Saraçoğlu, MD (Başakşehir Çam & Sakura City Hospital) · Sites: Istanbul, Başakşehir · Age: 4085 yrs
MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia
N/A
Active
PI: Dheeraj Gandhi, MD (University of Maryland, Baltimore) · Sites: Baltimore, Maryland · Age: 2175 yrs
Artificial Intelligence to Predict Surgical Outcomes and Assess Pain Neuromodulation in Trigeminal Neuralgia Subjects
N/A
Enrolling by Invitation
· Sites: Milan · Age: 1899 yrs
Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia
N/A
Actively Recruiting
· Sites: Alexandria; Cairo
Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia
N/A
Active
PI: Dr.SUFYAN AHMED, FCPS (KARACHI METROPOLITAN UNIVERSITY/ ABBASI SHAHEED HO) · Sites: Karachi, Sindh · Age: 1860 yrs
Pregabalin as an add-on Therapy to Carbamazepine in Trigeminal Neuralgia Patients
N/A
Actively Recruiting
PI: Shifa Akhtar, BDS (Post Graduate Institute of Dental Sciences ,Rohtak) · Sites: Rohtak, Haryana · Age: 2580 yrs
RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
N/A
Active
PI: John Fiveash, MD (University of Alabama at Birmingham) · Sites: Birmingham, Alabama · Age: 1899 yrs
Comparison of Pulsed and Thermal Radiofrequency for Trigeminal Neuralgia
N/A
Actively Recruiting
PI: Ahmed A Bessar, MD, PhD (Assistant Professor of Diagnostic and Intervention) · Sites: Zagazig, Sharqia Province · Age: 1860 yrs
Other5 trials
Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia
Actively Recruiting
PI: Albert Muñoz Vendrell, PhD (Hospital Universitari de Bellvitge) · Sites: L'Hospitalet de Llobregat, Barcelona · Age: 1899 yrs
The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for the Trigeminal Neuralgia
Actively Recruiting
· Sites: Beijing, Beijing Municipality · Age: 1875 yrs
Trigeminal Neuralgia Electrophysiology
Actively Recruiting
PI: David Darrow (University of Minnesota) · Sites: Minneapolis, Minnesota · Age: 1899 yrs
Emotion and Memory in Chronic Neuropathic Pain
Actively Recruiting
PI: Mojgan Hodaie, MD, MSc (Department of Neurosurgery, Toronto Western Hospit) · Sites: Toronto, Ontario · Age: 3560 yrs
Observational Study on the Treatment of Trigeminal Neuralgia by Radiosurgery
Actively Recruiting
· Sites: Monaco · Age: 1899 yrs

Specialists

24 foundView all specialists →
WP
Wendy J Dahl, PhD
UPTON, MA
Specialist
PI on 2 active trials
JM
John Fiveash, MD
BIRMINGHAM, AL
Specialist
PI on 5 active trials
MM
Meredith Barad, MD
STANFORD, CA
Specialist
PI on 1 active trial
MP
Mark Burish, MD, PhD
HOUSTON, TX
Specialist
PI on 1 active trial
AP
Ahmed A Bessar, MD, PhD
Specialist
PI on 2 active trials
MM
Mauricio F Farez, MD MPH
Specialist
PI on 1 active trial
AM
Anand Mahadevan, MD
FORT MYERS, FL
Specialist
PI on 3 active trials
CC
Clara Choi
Specialist
PI on 3 active trials50 Trigeminal neuralgia publications
SS
Scott Soltys
STANFORD, CA
Specialist
PI on 1 active trial
NM
Nevcihan ŞAHUTOĞLU BAL, MD
Specialist
PI on 1 active trial
MP
Ming Zhang, M.D. & Ph.D.
Specialist
PI on 2 active trials
SM
Salman A. Saleem, MBBS;FCPS
Specialist
PI on 1 active trial
JP
Jianqiao Fang, Ph.D,M.D
Specialist
PI on 1 active trial
AP
Athanasia Tsaroucha, Assoc. Prof.
Specialist
PI on 1 active trial
ES
Ehab H Shaker
Specialist
PI on 1 active trial
AP
Ahmed A Hashem, PhD
CLEVELAND, OH
Specialist
PI on 1 active trial
WP
Waleed Elmallah, PhD
CLEVELAND, OH
Specialist
PI on 1 active trial
AM
Amir Radfar, M.D,MPH
Specialist
PI on 1 active trial
AM
Alaa Alaji, Master
Specialist
PI on 1 active trial1 Trigeminal neuralgia publication
SM
Simran Mangwani Mordani, MD
Specialist
PI on 1 active trial
FM
Faro T Owiesy, M.D.
CORONA, CA
Specialist
PI on 1 active trial
EM
Ehab H Shaker, MD
Specialist
PI on 1 active trial
MS
Michael Schäfer
Specialist
PI on 1 active trial
EF
Edward McKintosh, FRCS(SN)
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Trigeminal neuralgia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Trigeminal neuralgiaForum →

No community posts yet. Be the first to share your experience with Trigeminal neuralgia.

Start the conversation →

Latest news about Trigeminal neuralgia

Disease timeline:

New recruiting trial: Impact of Individual Radiosensitivity on Late Toxicities of Radiosurgery in Essential Trigeminal Neuralgia

A new clinical trial is recruiting patients for Trigeminal neuralgia

New recruiting trial: Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol

A new clinical trial is recruiting patients for Trigeminal neuralgia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Trigeminal neuralgia

What is Trigeminal neuralgia?

Trigeminal neuralgia (TN), also known as tic douloureux or Fothergill's disease, is a chronic pain condition affecting the trigeminal nerve (cranial nerve V), which is responsible for carrying sensation from the face to the brain. It is characterized by sudden, severe, brief, stabbing, recurrent episodes of unilateral facial pain in the distribution of one or more branches of the trigeminal nerve, most commonly the maxillary (V2) and mandibular (V3) divisions. The pain is often described as electric shock-like and can be triggered by everyday activities such as eating, talking, brushing teeth,

How is Trigeminal neuralgia inherited?

Trigeminal neuralgia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Trigeminal neuralgia typically begin?

Typical onset of Trigeminal neuralgia is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Trigeminal neuralgia?

Yes — 20 recruiting clinical trials are currently listed for Trigeminal neuralgia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Trigeminal neuralgia?

24 specialists and care centers treating Trigeminal neuralgia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.